Assignee profile:

STALLERGENES

City:

ANTONY

Country:

France

Published Applications:

13

Last publication date:

2019-01-24

Patent Grants:

12

Last grant date:

2021-06-08

Top Inventors for applications by STALLERGENES

These are the the leading inventors for applications assigned to STALLERGENES:

Recent patent applications by STALLERGENES

STALLERGENES based in ANTONY, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-01-24 ✅ Patent 11,028,441 granted on 2021-06-08
US20190024177A1
Chemistry; metallurgy

IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy

#2 | 2017-12-28 ✅ Patent 10,884,002 granted on 2021-01-05
US20170370946A1
Physics

Sialylated fetuin-A as a marker of immunotherapy efficacy

#3 | 2017-08-17 ✅ Patent 11,015,221 granted on 2021-05-25
US20170233816A1
Chemistry; metallurgy

Markers of immune response

#4 | 2017-08-10 ✅ Patent 11,027,010 granted on 2021-06-08
US20170224810A1
Human necessities

Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids

#5 | 2017-02-16 ✅ Patent 10,610,586 granted on 2020-04-07
US20170043013A1
Human necessities

Compositions for antigen-specific induction of tolerance

#6 | 2016-12-22
US20160367631A1
Human necessities

C1q as a therapeutic agent of allergy and/or asthma

#7 | 2016-02-04 ✅ Patent 9,822,185 granted on 2017-11-21
US20160032018A1
Chemistry; metallurgy

Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa

#8 | 2014-12-25 ✅ Patent 10,190,166 granted on 2019-01-29
US20140377761A1
Chemistry; metallurgy

Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy

#9 | 2014-04-24 ✅ Patent 10,101,341 granted on 2018-10-16
US20140112955A1
Physics

Biomarkers of immunotherapy efficacy

#10 | 2014-03-20 ✅ Patent 9,480,748 granted on 2016-11-01
US20140079795A1
Human necessities

Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance

#11 | 2012-06-14 ✅ Patent 9,795,644 granted on 2017-10-24
US20120148626A1
Human necessities

Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids

#12 | 2011-12-01 ✅ Patent 9,868,770 granted on 2018-01-16
US20110293665A1
Chemistry; metallurgy

Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposes

#13 | 2008-09-25 ✅ Patent 9,555,102 granted on 2017-01-31
US20080233155A1
Human necessities

Compositions for antigen-specific induction of tolerance

Also check out STALLERGENES's (Antony, France) applicant profile with 5 patent applications submitted.

AssigneeID:

116803